CRIPTO and embryonal carcinoma: To assess the functional consequences of these interactions, we utilized NTERA‐2 cells, a human embryonal carcinoma cell line that endogenously expresses Cripto‐1 (Dono et al., 1991; Watanabe et al., 2010).